Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/12/2020
CMS memo removes cost sharing on COVID-19 tests, eases Rx refill limits
COVID-19 diagnostic tests will be covered by benefits, and Medicare Advantage and Part D plans will waive certain requirements to help prevent the spread of COVID-19. - 3/12/2020
NACDS offers resources for virtual congressional outreach
In the wake of the cancellation of its RxIMPACT Day on Capitol Hill due to the coronavirus, NACDS is urging members to use its virtual fly-in resource. - 3/11/2020
Prime Liberty Pharmacy earns Compliance Team's Exemplary Provider Accreditation
Prime Liberty Pharmacy received accreditation from The Compliance Team for community pharmacy and long-term care, as well as in durable medical equipment, prosthetics, orthotics and supplies. - 3/11/2020
NACDS praises New Mexico law expanding pharmacist-provided services
NACDS lauded the collaborative work that led to the enactment of House Bill 42 that improves access to health care for citizens of New Mexico. - 3/11/2020
Hi-School Pharmacy Services receives Compliance Team's Community Pharmacy Accreditation
The Compliance Team has awarded Community Pharmacy Accreditation to 19 Hi-School Pharmacy Services locations. - 3/11/2020
NABP taps Lemrey “Al” Carter as executive director/secretary
Lemrey "Al" Carter will succeed Carmen Catizone as NABP executive director. - 3/10/2020
Euclid Medical Products unveils Axial Multi-Dose Machines
Euclid Medical Products is debuting a new line of next generation strip adherence pouch packaging machines and consumables with unit- and multi-dose capabilities. - 3/10/2020
NACDS Foundation, universities collaborate on medication management
The NACDS Foundation is providing matching funds to an MTM program designed to help Minnesota patients with chronic diseases. - 3/9/2020
Mylan launches generic Advair Diskus in Canada
Advair Diskus had a market value of $113.9 million in Canada for the 12 months ended Dec. 31, 2019, according to IQVIA. - 3/9/2020
Study: Expanding biosimilar use could reduce patient costs
Biosimilars could reduce patient's out-of-pocket costs by 17%, according to a new study by the Center for Medical Economics at the Pacific Research Institute.
